SD HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
New Drug, New Attitude, New Day at Pharma Co.
Arena Pharmaceuticals Begins to Bounce Back from Belviq FailureIts diet pill was a commercial flop that almost sent Arena Pharmaceuticals Inc. to the grave. But now, following a major makeover, the company’s new experimental medicines could bring renewed life to the San Diego biotech. July 25, 2017 7:59 a.m. $$ ShareFDA Grants Special Status to Biotech's Drug
Regulators with the U.S. Food and Drug Administration have handed local biotech Samumed LLC a special classification for one of its drug programs, granting the company a number of perks.
July 25, 2017 5:38 p.m. share »
Diagnostics Co. Must Wait for the Results
One of San Diego’s bigger (yet little-known) public companies, Quidel Corp., just inked a deal that could double its annual revenue. But the deal’s closure is dependent on outside forces that may or may not go Quidel’s way.
July 25, 2017 8:04 a.m. share »Effector Therapeutics Raises $38.6 Million From Pfizer Venture
Local biotech Effector Therapeutics Inc. has raised $38.6 million in a Series C venture capital round led by big pharma investor Pfizer Venture Investments.
July 24, 2017 3:57 p.m. share »
New Drug, New Attitude: New Day at Pharma Company
Its diet pill was a commercial flop that almost sent Arena Pharmaceuticals Inc. to the grave. But now, following a major makeover, the company’s new experimental medicines could bring renewed life to the San Diego biotech.
July 21, 2017 2:38 p.m. share »Neurocrine Names Julie Cooke as Chief People Officer
Local drugmaker Neurocrine Biosciences Inc. has hired Julie Cooke to serve as part of the company’s management committee with the title chief people officer.
July 21, 2017 1:16 p.m. share »Windward Life Care Is Acquiring Lifeline Care at Home
A local aging services company called Windward Life Care has acquired San Diego’s longstanding senior care organization, Lifeline Care at Home.
July 21, 2017 11:32 a.m. share »Imprimis Pharmaceuticals Borrows $16 Million
San Diego drugmaker Imprimis Pharmaceuticals Inc. has entered into a $16 million loan agreement with SWK Funding and its partners, the company announced Thursday.
July 20, 2017 4:34 p.m. share »Aspyrian Therapeutics Raises $15.1 Million
San Diego’s Aspyrian Therapeutics Inc. has raised $15.1 million in a Series B-1 financing round. The company expects the round will increase to $19 million in the next few weeks.
July 20, 2017 2:40 p.m. share »
Sommetrics Names Corbet Lancaster Senior VP of Finance
A small medtech company in Vista, Sommetrics, has recruited Corbet “Cory” Lancaster to serve as the company’s new senior vice president of finance.
July 19, 2017 4:44 p.m. share »
Chinese PE Firm Closes $400 Million Fund
A Chinese private equity firm that has its eye on San Diego biotech just closed a $400 million fund, its second and biggest yet.
July 19, 2017 2:18 p.m. share »Ionis Pharmaceuticals Earns $10 Million Payment From Biogen
Carlsbad drugmaker Ionis Pharmaceuticals Inc. has earned a $10 million paycheck from its big biotech partner Biogen Inc.
July 18, 2017 9:44 a.m. share »
Phoenix Molecular Appoints Chief Scientific Officer
A longtime member of San Diego’s life science community, Dr. Gerrit Los, has been named chief scientific officer at Phoenix Molecular Designs.
July 18, 2017 9:41 a.m. share »Steve Powell Named CEO of SynteractHCR
San Diego-based contract research organization SynteractHCR Holdings Corp. has hired Steve Powell as its new chief executive officer, replacing Wendel Barr, the firm’s CEO for six years.
July 17, 2017 3:06 p.m. share »Quidel to Acquire Assets of Alere for $440 Million
Quidel Corp., a diagnostic test maker in San Diego, has a $440 million deal pending to purchase assets from East Coast diagnostic firm Alere Inc.
July 17, 2017 2:56 p.m. share »-
prev
- next
